Pictet Asset Management (UK)’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-149,238
Closed -$12M 889
2016
Q4
$12M Sell
149,238
-300
-0.2% -$23.8K 0.04% 413
2016
Q3
$11.9M Sell
149,538
-100
-0.1% -$8.07K 0.04% 398
2016
Q2
$11.7M Sell
149,638
-300
-0.2% -$21.4K 0.05% 400
2016
Q1
$8.05M Buy
149,938
+1,700
+1% +$92.6K 0.04% 434
2015
Q4
$9.16M Sell
148,238
-7,000
-5% -$441K 0.04% 423
2015
Q3
$9.79M Buy
155,238
+500
+0.3% +$35.7K 0.04% 405
2015
Q2
$11.4M Sell
154,738
-6,300
-4% -$455K 0.05% 398
2015
Q1
$11.3M Sell
161,038
-2,700
-2% -$180K 0.05% 402
2014
Q4
$10.6M Buy
163,738
+6,738
+4% +$434K 0.05% 389
2014
Q3
$9.44M Sell
157,000
-1,800
-1% -$118K 0.05% 389
2014
Q2
$11M Sell
158,800
-13,900
-8% -$901K 0.05% 366
2014
Q1
$11.3M Buy
172,700
+1,400
+0.8% +$91.1K 0.06% 350
2013
Q4
$10.6M Buy
171,300
+28,000
+20% +$1.62M 0.05% 345
2013
Q3
$7.69M Sell
143,300
-27,900
-16% -$1.44M 0.04% 394
2013
Q2
$7.81M Buy
+171,200
New +$7.42M 0.04% 369

Other funds holding STJ

Pictet Asset Management (UK)'s STJ Position: Q1 2017 in Review

Pictet Asset Management (UK) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 149,238 shares — an estimated $12M sold.

Pictet Asset Management (UK) first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $12M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Pictet Asset Management (UK) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 149,238 St Jude Medical shares in Q1 2017, an estimated $12M.
  • Pictet Asset Management (UK) first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Pictet Asset Management (UK)'s St Jude Medical position peaked at $12M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2017, filed 4 May 2017.